JP2022552723A - 細胞状態を測定するための方法及びシステム - Google Patents

細胞状態を測定するための方法及びシステム Download PDF

Info

Publication number
JP2022552723A
JP2022552723A JP2022523301A JP2022523301A JP2022552723A JP 2022552723 A JP2022552723 A JP 2022552723A JP 2022523301 A JP2022523301 A JP 2022523301A JP 2022523301 A JP2022523301 A JP 2022523301A JP 2022552723 A JP2022552723 A JP 2022552723A
Authority
JP
Japan
Prior art keywords
cell
dna
cell type
read data
abundance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022523301A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022552723A5 (https=
Inventor
チャウドゥリ，アーデル
ニューマン，アーロン
エラヒ，イルファン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington University in St Louis WUSTL
Leland Stanford Junior University
Original Assignee
Washington University in St Louis WUSTL
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington University in St Louis WUSTL, Leland Stanford Junior University filed Critical Washington University in St Louis WUSTL
Publication of JP2022552723A publication Critical patent/JP2022552723A/ja
Publication of JP2022552723A5 publication Critical patent/JP2022552723A5/ja
Priority to JP2026000406A priority Critical patent/JP2026064241A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
JP2022523301A 2019-10-18 2020-10-18 細胞状態を測定するための方法及びシステム Pending JP2022552723A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026000406A JP2026064241A (ja) 2019-10-18 2026-01-05 細胞状態を測定するための方法及びシステム

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962916961P 2019-10-18 2019-10-18
US62/916,961 2019-10-18
PCT/US2020/056218 WO2021077063A1 (en) 2019-10-18 2020-10-18 Methods and systems for measuring cell states

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026000406A Division JP2026064241A (ja) 2019-10-18 2026-01-05 細胞状態を測定するための方法及びシステム

Publications (2)

Publication Number Publication Date
JP2022552723A true JP2022552723A (ja) 2022-12-19
JP2022552723A5 JP2022552723A5 (https=) 2023-10-25

Family

ID=75538680

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022523301A Pending JP2022552723A (ja) 2019-10-18 2020-10-18 細胞状態を測定するための方法及びシステム
JP2026000406A Pending JP2026064241A (ja) 2019-10-18 2026-01-05 細胞状態を測定するための方法及びシステム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026000406A Pending JP2026064241A (ja) 2019-10-18 2026-01-05 細胞状態を測定するための方法及びシステム

Country Status (7)

Country Link
US (1) US20240401134A1 (https=)
EP (1) EP4045685A4 (https=)
JP (2) JP2022552723A (https=)
CN (1) CN114746559A (https=)
AU (1) AU2020365150A1 (https=)
CA (1) CA3155073A1 (https=)
WO (1) WO2021077063A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4373972A4 (en) * 2021-07-23 2025-06-18 Georgetown University USE OF METHYLATED CIRCULATING FREE DNA TO DETECT TISSUE INJURY
WO2023129969A1 (en) * 2021-12-30 2023-07-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods for identifying cell types
WO2023178319A2 (en) * 2022-03-17 2023-09-21 Washington University Methods and systems for measuring multiple cell states
EP4573217A1 (en) * 2022-08-18 2025-06-25 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. A method for determining the tissue or cell of origin of dna
CA3268032A1 (en) * 2022-09-23 2024-03-28 Flagship Pioneering Innovations Vi, Llc NUCLEIC ACID AMPLIFICATION PROCESSES
WO2024081689A1 (en) * 2022-10-11 2024-04-18 LiquidCell Dx Inc. Tumor microenvironment by liquid biopsy
WO2024124207A2 (en) * 2022-12-08 2024-06-13 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for cell-free nucleic acids methylation assessment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015169857A1 (en) * 2014-05-07 2015-11-12 Université Libre de Bruxelles Breast cancer epigenetic markers useful in anthracycline treatment prognosis
WO2018119216A1 (en) * 2016-12-21 2018-06-28 The Regents Of The University Of California Deconvolution and detection of rare dna in plasma
WO2019200410A1 (en) * 2018-04-13 2019-10-17 Freenome Holdings, Inc. Machine learning implementation for multi-analyte assay of biological samples

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012045888A1 (en) * 2010-10-08 2012-04-12 Epiontis Gmbh Method for determining cancer patient survival based on analyzing tumor-infiltrating overall t-lymphocytes
WO2015159292A2 (en) * 2014-04-14 2015-10-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. A method and kit for determining the tissue or cell origin of dna
CA2971129A1 (en) * 2015-01-22 2016-07-28 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for determining proportions of distinct cell subsets
US10689706B2 (en) * 2015-07-20 2020-06-23 The Chinese University Of Hong Kong Methylation pattern analysis of haplotypes in tissues in a DNA mixture
WO2017201400A1 (en) * 2016-05-19 2017-11-23 The Regents Of The University Of California Determination of cell types in mixtures using targeted bisulfite sequencing
EP3382033B1 (en) * 2017-03-30 2020-08-05 Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen Method for determining blood counts based on dna methylation
EP3655955B1 (en) * 2017-07-21 2025-04-09 The Board of Trustees of the Leland Stanford Junior University Systems and methods for analyzing mixed cell populations

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015169857A1 (en) * 2014-05-07 2015-11-12 Université Libre de Bruxelles Breast cancer epigenetic markers useful in anthracycline treatment prognosis
WO2018119216A1 (en) * 2016-12-21 2018-06-28 The Regents Of The University Of California Deconvolution and detection of rare dna in plasma
WO2019200410A1 (en) * 2018-04-13 2019-10-17 Freenome Holdings, Inc. Machine learning implementation for multi-analyte assay of biological samples

Also Published As

Publication number Publication date
JP2026064241A (ja) 2026-04-13
WO2021077063A1 (en) 2021-04-22
AU2020365150A1 (en) 2022-05-26
CN114746559A (zh) 2022-07-12
EP4045685A1 (en) 2022-08-24
CA3155073A1 (en) 2021-04-22
EP4045685A4 (en) 2023-11-15
US20240401134A1 (en) 2024-12-05

Similar Documents

Publication Publication Date Title
D’Adamo et al. The future is now? Clinical and translational aspects of “Omics” technologies
Jamshidi et al. Evaluation of cell-free DNA approaches for multi-cancer early detection
Biasci et al. A blood-based prognostic biomarker in IBD
JP2022552723A (ja) 細胞状態を測定するための方法及びシステム
Chater-Diehl et al. Anatomy of DNA methylation signatures: Emerging insights and applications
JP2021521536A (ja) 生体試料の多検体アッセイのための機械学習実装
Michuda et al. Validation of a transcriptome-based assay for classifying cancers of unknown primary origin
US20140303034A1 (en) Predicting prognosis in classic hodgkin lymphoma
Li et al. TimiGP: Inferring cell-cell interactions and prognostic associations in the tumor immune microenvironment through gene pairs
Gil-Manso et al. Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission
Kreitmann et al. Mortality prediction in sepsis with an immune-related transcriptomics signature: a multi-cohort analysis
Glass et al. Multi-omic profiling reveals the endogenous and neoplastic responses to immunotherapies in cutaneous T cell lymphoma
Peng et al. Development and validation of an integrative methylation signature and nomogram for predicting survival in clear cell renal cell carcinoma
Cakmak et al. Predicting the predisposition to colorectal cancer based on SNP profiles of immune phenotypes using supervised learning models
Chandran Pathway to biomarker discovery in psoriatic arthritis
Krasnitz et al. Early detection of cancer in blood using single-cell analysis: a proposal
Lu et al. Detection and characterization of circulating tumour cells from frozen peripheral blood mononuclear cells
Muller et al. Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer
Kong et al. Circulation immune cell landscape in canonical pathogenesis of colorectal adenocarcinoma by CyTOF analysis
Cao et al. Predicting tumor immune microenvironment and checkpoint therapy response of head & neck cancer patients from blood immune single-cell transcriptomics
Zuckerbrot-Schuldenfrei et al. Breast cancer is detectable from peripheral blood using machine learning over T cell receptor repertoires
Asghari et al. Integration of spatial multiplexed protein imaging and transcriptomics in the human kidney tracks the regenerative potential timeline of proximal tubules
US20250197939A1 (en) Methods and Systems for Measuring Multiple Cell States
Trent Hematologic Biomarkers and AI in Breast Cancer: A New Frontier for Risk Stratification and Treatment Response Prediction
Zhang et al. Meta-analytic microbiome target discovery for immune checkpoint inhibitor response in advanced melanoma

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231017

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231017

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20241030

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241105

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250131

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250507

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250902

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260105

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260414